Global Basic Infusion Medicament Market Growth 2025-2031

Publication ID:

LPI02253526

Publication Date:

February 27, 2025

Pages:

142

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Basic Infusion Medicament market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淏asic Infusion Medicament Industry Forecast鈥� looks at past sales and reviews total world Basic Infusion Medicament sales in 2024, providing a comprehensive analysis by region and market sector of projected Basic Infusion Medicament sales for 2025 through 2031. With Basic Infusion Medicament sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Basic Infusion Medicament industry.
This Insight Report provides a comprehensive analysis of the global Basic Infusion Medicament landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Basic Infusion Medicament portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Basic Infusion Medicament market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Basic Infusion Medicament and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Basic Infusion Medicament.
This report presents a comprehensive overview, market shares, and growth opportunities of Basic Infusion Medicament market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Glucose
Sodium Chloride
Compound Products
Segmentation by Application:
max. 100ml
250ml
500ml
min. 1L
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi'an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
Key Questions Addressed in this Report
What is the 10-year outlook for the global Basic Infusion Medicament market?
What factors are driving Basic Infusion Medicament market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Basic Infusion Medicament market opportunities vary by end market size?
How does Basic Infusion Medicament break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Basic Infusion Medicament Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Basic Infusion Medicament by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Basic Infusion Medicament by Country/Region, 2020, 2024 & 2031
2.2 Basic Infusion Medicament Segment by Type
2.2.1 Glucose
2.2.2 Sodium Chloride
2.2.3 Compound Products
2.3 Basic Infusion Medicament Sales by Type
2.3.1 Global Basic Infusion Medicament Sales Market Share by Type (2020-2025)
2.3.2 Global Basic Infusion Medicament Revenue and Market Share by Type (2020-2025)
2.3.3 Global Basic Infusion Medicament Sale Price by Type (2020-2025)
2.4 Basic Infusion Medicament Segment by Application
2.4.1 max. 100ml
2.4.2 250ml
2.4.3 500ml
2.4.4 min. 1L
2.5 Basic Infusion Medicament Sales by Application
2.5.1 Global Basic Infusion Medicament Sale Market Share by Application (2020-2025)
2.5.2 Global Basic Infusion Medicament Revenue and Market Share by Application (2020-2025)
2.5.3 Global Basic Infusion Medicament Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Basic Infusion Medicament Breakdown Data by Company
3.1.1 Global Basic Infusion Medicament Annual Sales by Company (2020-2025)
3.1.2 Global Basic Infusion Medicament Sales Market Share by Company (2020-2025)
3.2 Global Basic Infusion Medicament Annual Revenue by Company (2020-2025)
3.2.1 Global Basic Infusion Medicament Revenue by Company (2020-2025)
3.2.2 Global Basic Infusion Medicament Revenue Market Share by Company (2020-2025)
3.3 Global Basic Infusion Medicament Sale Price by Company
3.4 Key Manufacturers Basic Infusion Medicament Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Basic Infusion Medicament Product Location Distribution
3.4.2 Players Basic Infusion Medicament Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Basic Infusion Medicament by Geographic Region
4.1 World Historic Basic Infusion Medicament Market Size by Geographic Region (2020-2025)
4.1.1 Global Basic Infusion Medicament Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Basic Infusion Medicament Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Basic Infusion Medicament Market Size by Country/Region (2020-2025)
4.2.1 Global Basic Infusion Medicament Annual Sales by Country/Region (2020-2025)
4.2.2 Global Basic Infusion Medicament Annual Revenue by Country/Region (2020-2025)
4.3 Americas Basic Infusion Medicament Sales Growth
4.4 APAC Basic Infusion Medicament Sales Growth
4.5 Europe Basic Infusion Medicament Sales Growth
4.6 Middle East & Africa Basic Infusion Medicament Sales Growth
5 Americas
5.1 Americas Basic Infusion Medicament Sales by Country
5.1.1 Americas Basic Infusion Medicament Sales by Country (2020-2025)
5.1.2 Americas Basic Infusion Medicament Revenue by Country (2020-2025)
5.2 Americas Basic Infusion Medicament Sales by Type (2020-2025)
5.3 Americas Basic Infusion Medicament Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Basic Infusion Medicament Sales by Region
6.1.1 APAC Basic Infusion Medicament Sales by Region (2020-2025)
6.1.2 APAC Basic Infusion Medicament Revenue by Region (2020-2025)
6.2 APAC Basic Infusion Medicament Sales by Type (2020-2025)
6.3 APAC Basic Infusion Medicament Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Basic Infusion Medicament by Country
7.1.1 Europe Basic Infusion Medicament Sales by Country (2020-2025)
7.1.2 Europe Basic Infusion Medicament Revenue by Country (2020-2025)
7.2 Europe Basic Infusion Medicament Sales by Type (2020-2025)
7.3 Europe Basic Infusion Medicament Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Basic Infusion Medicament by Country
8.1.1 Middle East & Africa Basic Infusion Medicament Sales by Country (2020-2025)
8.1.2 Middle East & Africa Basic Infusion Medicament Revenue by Country (2020-2025)
8.2 Middle East & Africa Basic Infusion Medicament Sales by Type (2020-2025)
8.3 Middle East & Africa Basic Infusion Medicament Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Basic Infusion Medicament
10.3 Manufacturing Process Analysis of Basic Infusion Medicament
10.4 Industry Chain Structure of Basic Infusion Medicament
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Basic Infusion Medicament Distributors
11.3 Basic Infusion Medicament Customer
12 World Forecast Review for Basic Infusion Medicament by Geographic Region
12.1 Global Basic Infusion Medicament Market Size Forecast by Region
12.1.1 Global Basic Infusion Medicament Forecast by Region (2026-2031)
12.1.2 Global Basic Infusion Medicament Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Basic Infusion Medicament Forecast by Type (2026-2031)
12.7 Global Basic Infusion Medicament Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Basic Infusion Medicament Product Portfolios and Specifications
13.1.3 Baxter Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 B. Braun
13.2.1 B. Braun Company Information
13.2.2 B. Braun Basic Infusion Medicament Product Portfolios and Specifications
13.2.3 B. Braun Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 B. Braun Main Business Overview
13.2.5 B. Braun Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi Basic Infusion Medicament Product Portfolios and Specifications
13.3.3 Fresenius Kabi Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Kelun Pharma
13.4.1 Kelun Pharma Company Information
13.4.2 Kelun Pharma Basic Infusion Medicament Product Portfolios and Specifications
13.4.3 Kelun Pharma Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Kelun Pharma Main Business Overview
13.4.5 Kelun Pharma Latest Developments
13.5 Otsuka Pharmaceutical
13.5.1 Otsuka Pharmaceutical Company Information
13.5.2 Otsuka Pharmaceutical Basic Infusion Medicament Product Portfolios and Specifications
13.5.3 Otsuka Pharmaceutical Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Otsuka Pharmaceutical Main Business Overview
13.5.5 Otsuka Pharmaceutical Latest Developments
13.6 JW Pharmaceutical
13.6.1 JW Pharmaceutical Company Information
13.6.2 JW Pharmaceutical Basic Infusion Medicament Product Portfolios and Specifications
13.6.3 JW Pharmaceutical Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 JW Pharmaceutical Main Business Overview
13.6.5 JW Pharmaceutical Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Basic Infusion Medicament Product Portfolios and Specifications
13.7.3 Pfizer Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Teva Pharmaceutical
13.8.1 Teva Pharmaceutical Company Information
13.8.2 Teva Pharmaceutical Basic Infusion Medicament Product Portfolios and Specifications
13.8.3 Teva Pharmaceutical Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Teva Pharmaceutical Main Business Overview
13.8.5 Teva Pharmaceutical Latest Developments
13.9 Haisco Pharmaceutical Group
13.9.1 Haisco Pharmaceutical Group Company Information
13.9.2 Haisco Pharmaceutical Group Basic Infusion Medicament Product Portfolios and Specifications
13.9.3 Haisco Pharmaceutical Group Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Haisco Pharmaceutical Group Main Business Overview
13.9.5 Haisco Pharmaceutical Group Latest Developments
13.10 King York
13.10.1 King York Company Information
13.10.2 King York Basic Infusion Medicament Product Portfolios and Specifications
13.10.3 King York Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 King York Main Business Overview
13.10.5 King York Latest Developments
13.11 Cisen
13.11.1 Cisen Company Information
13.11.2 Cisen Basic Infusion Medicament Product Portfolios and Specifications
13.11.3 Cisen Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Cisen Main Business Overview
13.11.5 Cisen Latest Developments
13.12 Lummy
13.12.1 Lummy Company Information
13.12.2 Lummy Basic Infusion Medicament Product Portfolios and Specifications
13.12.3 Lummy Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Lummy Main Business Overview
13.12.5 Lummy Latest Developments
13.13 Grand Life Sciences
13.13.1 Grand Life Sciences Company Information
13.13.2 Grand Life Sciences Basic Infusion Medicament Product Portfolios and Specifications
13.13.3 Grand Life Sciences Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Grand Life Sciences Main Business Overview
13.13.5 Grand Life Sciences Latest Developments
13.14 Medisan
13.14.1 Medisan Company Information
13.14.2 Medisan Basic Infusion Medicament Product Portfolios and Specifications
13.14.3 Medisan Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Medisan Main Business Overview
13.14.5 Medisan Latest Developments
13.15 BBCA Pharmaceutical
13.15.1 BBCA Pharmaceutical Company Information
13.15.2 BBCA Pharmaceutical Basic Infusion Medicament Product Portfolios and Specifications
13.15.3 BBCA Pharmaceutical Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 BBCA Pharmaceutical Main Business Overview
13.15.5 BBCA Pharmaceutical Latest Developments
13.16 Biokin Pharmaceutical
13.16.1 Biokin Pharmaceutical Company Information
13.16.2 Biokin Pharmaceutical Basic Infusion Medicament Product Portfolios and Specifications
13.16.3 Biokin Pharmaceutical Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Biokin Pharmaceutical Main Business Overview
13.16.5 Biokin Pharmaceutical Latest Developments
13.17 Xi'an Libang Pharmaceutical
13.17.1 Xi'an Libang Pharmaceutical Company Information
13.17.2 Xi'an Libang Pharmaceutical Basic Infusion Medicament Product Portfolios and Specifications
13.17.3 Xi'an Libang Pharmaceutical Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Xi'an Libang Pharmaceutical Main Business Overview
13.17.5 Xi'an Libang Pharmaceutical Latest Developments
13.18 Lionco Pharmaceutical
13.18.1 Lionco Pharmaceutical Company Information
13.18.2 Lionco Pharmaceutical Basic Infusion Medicament Product Portfolios and Specifications
13.18.3 Lionco Pharmaceutical Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Lionco Pharmaceutical Main Business Overview
13.18.5 Lionco Pharmaceutical Latest Developments
13.19 China Meheco Kangli
13.19.1 China Meheco Kangli Company Information
13.19.2 China Meheco Kangli Basic Infusion Medicament Product Portfolios and Specifications
13.19.3 China Meheco Kangli Basic Infusion Medicament Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 China Meheco Kangli Main Business Overview
13.19.5 China Meheco Kangli Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂